# FDA Inspection 1275474 - GraftSource, LLC - June 16, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/graftsource-llc/a9a4e1f5-bc63-4132-a28e-045d4a3b74fa
Source feed: FDA_Inspections

> FDA Inspection 1275474 for GraftSource, LLC on June 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275474
- Company Name: GraftSource, LLC
- Inspection Date: 2025-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1275474 - 2025-06-16](https://www.globalkeysolutions.net/records/fda_inspections/graftsource-llc/e1508fee-b390-4e8e-98cd-5063b87f6a89)
- [FDA Inspection 1023822 - 2017-06-26](https://www.globalkeysolutions.net/records/fda_inspections/graftsource-llc/ba2200c9-f4d1-4490-8e83-5e48a5167970)

Company: https://www.globalkeysolutions.net/companies/graftsource-llc/77a3504a-cd5c-4bd5-a24d-2f87d43e1028

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d